Print Page | Contact Us | Sign In | JOIN FPA
Legislative Issues

2020 Florida Legislative Session

Last Updated: 2/3/20

For questions, comments, and concerns regarding the potential impact of the proposed legislation on the profession and practice of pharmacy, and to inquire about ways to get involved in FPA's advocacy efforts please contact:

 

Bill No. Summary Status  FPA Stance

 

HB 25 (Monitor)

SB 242 (Monitor)

Cannabis Offenses

HB Sponsor: Jones

SB Sponsor: Braynon II

Would reduce criminal penalties for possession of limited amounts of cannabis & products containing limited amounts of THC.

HB Referred to:

Criminal Justice Subcommittee

Justice Appropriations Subcommittee

Judiciary Committee

SB Referred to:

Criminal Justice

Appropriations Subcommittee on Criminal and Civil Justice

Appropriations


 

 

HB 41 (Monitor)

SB 180 (Monitor)

Conversion Therapy

House Sponsor: Grieco

Senate Sponsor: Rodriguez

Would prohibit certain licensed practitioners from practicing or performing conversion therapy on an individual who is less than 18 years of age.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

SB Referred to:

Health Policy

Children, Families, and Elder Affairs

Rules

 

SB 58 (Monitor)

Prescription Drug Donation Repository

Sponsor: Book

Would allow the Department of Health to contract with third-party vendors to facilitate the collection of donated prescription drugs and supplies and their re-dispersion to patients; the types of medications and supplies and eligible donors and patients for the program are defined in the bill. A registry of participating repositories and available donated medications will be maintain. Donated medications can not be resold.

 

Referred to:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations 

 

HB 59 (Oppose)

SB708 (Oppose)

Automated Pharmacy Systems

Sponsor: Willhite (House) Talking Points
                 Hutson (Senate)

Would authorize community pharmacies to use automated pharmacy systems for outpatient dispensing of medications not listed as schedule II - V in locations that do not employee a full-time pharmacist. These medications must be included as part of the inventory of the controlling community pharmacy. The Board of Pharmacy is required to adopt these rules.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

SB Referred to:

Health Policy

Innovation, Industry and Technology

Rules

 
SB 64 (Monitor)

Exemptions from School-Entry Health Requirements

Sponsor: Book

Would remove exemptions from school-entry health examinations and immunization requirements for religious reasons.

Referred to:

Health Policy

Education

Rules

 

HB 77 (Support)

SB 66 (Support)

Student Loans and Scholarship Obligations of Healthcare Practitioners

HB Sponsor: Goff-Marcil

SB Sponsor: Cruz

Would establish that a healthcare practitioner’s failure to repay a student loan or to comply with service scholarship obligations does not constitute grounds for disciplinary action.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

 

SB Referred to:

Health Policy

Appropriations Subcommittee on Education

Appropriations 

 
SB 98 (Monitor)

Medical Marijuana Identification Cards for Service-Disabled Veterans 

Sponsor: Cruz

Would prohibit the Department of Health from charging a fee for the issuance, replacement, or renewal of an identification card for the medical use of marijuana for a service-disabled veteran or his/her caregiver if a specified form is included with the identification card application.

Referred to:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

 

SB 100 (Monitor)

HB 57 (Monitor)

Dispensing Medicinal Drugs

Senate Sponsor: Harrell

House Sponsor: Willhite 

Would authorize individuals licensed to prescribe medicinal drugs to dispense a 48-hour supply, rather than a 24-hour supply, of such drugs to any patient, including a discharged patient, under certain circumstances, and allows for a 72-hour supply if a state of emergency has been declared in the area.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

SB Referred to:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

 

HB 109 (Monitor)

SB 116 (Monitor)

Prescription Insulin Drugs

House Sponsor: Casello, Duran

Senate Sponsor: Cruz

Would require individual and group health insurance policies, respectively, to cap an insured’s monthly (30-day supply) cost-sharing obligation for covered prescription insulin drugs at a specified amount regardless of the type of insulin.

HB Referred to:

Health Market Reform Subcommittee

Appropriations Committee

Health and Human Services Committee

SB Referred to:

Banking and Insurance

Appropriations Subcommittee on Agriculture, Environment, and General Government

Appropriations

 
SB 120 (Monitor)

Naloxone in Schools

Sponsor: Pizzo

Would authorize a public school to purchase a supply of the opioid antagonist naloxone and require the school district to adopt a protocol for the administration of naloxone; would establish that a school district and its employees and agents and the physician who provides the protocol are not liable for any injury arising from the administration of the naloxone pursuant to the protocol.

A licensed physician would be required to develop the policy for the entire district. Each school would purchase naloxone from a wholesaler. Medication would be stored in a secured location on campus (i.e. school nurse/clinic). Examples of other states: a Maryland school district paid $12,500 for their 125 schools to carry two doses in their school clinic. 

Referred to:

Education

Health Policy

Rules

 

HB 113 (Monitor)

SB 172 (Monitor)

Florida Drug and Cosmetic Act

House Sponsor: Roach

Senate Sponsor: Bradley

An act relating to the Florida Drug and Cosmetic Act amending s. 499.002 preempting the regulation of over-the-counter proprietary drugs or cosmetics to the state. New language would read "Notwithstanding any other law or local ordinance or regulation to the contrary, the regulation of over-the-counter proprietary drugs and cosmetics is expressly preempted to the state."

HB Referred to:

Health Quality Subcommittee

Local, Federal and Veterans Affairs Subcommittee

Health and Human Services Committee

SB Referred to:

Community Affairs

Innovation, Industry, and Technology

Rules

 
SB 204 (Monitor)

Delivery of Nursing Services

Sponsor: Braynon

Creating the “Florida Hospital Patient Protection Act”; requiring that each health care facility implement a staffing plan that provides minimum direct care registered nurse staffing levels; prohibiting a health care facility from assigning unlicensed personnel to perform functions or tasks that should be performed by a licensed or registered nurse; requiring a direct care registered nurse to initiate action or to change a decision or an activity relating to a patient’s health care under certain circumstances; prohibiting a health care facility from interfering with the right of direct care registered nurses to organize, bargain collectively, and engage in concerted activity under a federal act.

Referred to:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

 
HB 151 (Monitor)

Use of Regulated Substances

HB Sponsor: Toledo, Duran, Willhite

Would prohibit physicians from issuing certificate for marijuana in form for smoking to patient under 21 years of age. Would prohibit the sale of flavored liquid nicotine products intended for certain uses. Would revise the prohibited age related to sale, delivery, gift, possession, & purchase of tobacco products from 18 years of age to 21 years of age.

HB Filed  
HB 177 (Monitor)

Prescription Drug Donation Repository Program

HB Sponsor: Yarborough, Duran

Would create a Prescription Drug Donation Repository Program within the DOH, and provide criteria & conditions for donation of prescription drugs & supplies from certain authorized entities for dispensing to eligible patients. Would also authorize the Governor to waive program patient eligibility requirements during declared state of emergency.

HB Filed   
SB 212 (Monitor)

Medical Marijuana Retail Facilities

SB Sponsor: Thurston

This bill would prohibit qualified physicians and caregivers from being employed by or having an economic interest in a medical marijuana retail facility

SB Referred to: 

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

Rules

 
SB 318 (Monitor)

Sale of Sunscreen

SB Sponsor: Stewart

Would prohibit the sale, offer for sale, or distribution of certain sunscreen products to a consumer who does not have a prescription for such product due to the negative environmental impact of certain ingredients. Regulated products would include those with the following listed ingredients: oxybenzone and octinoxate

SB Filed  
SB 350 (Monitor)

Impaired Practitioner Program

SB Sponsor: Bean

Would create a  student evaluation program within the DOH to fund the evaluation of students who are preparing for licensure as practitioners and who have or are suspected of having an impairment that could affect a student’s ability to practice with skill and safety if the student were licensed, registered, or certified.


 

HB389 (Support)

SB714 (Support)

Testing for and Treatment of Influenza and Streptococcus

Sponsor: Sirois (House) Talking Points
                 Hutson (Senate)

Requiring specified licensed pharmacists to report certain information to the Department of Health; authorizing pharmacists to test for and treat influenza and streptococcus and providing requirements relating thereto; requiring that a pharmacist notify a patient’s primary care provider within a specified time period after providing any such testing or treatment, etc.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

SB Referred to:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

 

HB599 (Support)

SB1094 (Support)

Consultant Pharmacists - Talking Points

Sponsor: Ana Maria Rodriguez (House)

Manny Diaz (Senate)

Requires pharmacist to complete additional training consultant pharmacist licensure; authorizes consultant pharmacist to perform specified services; prohibits consultant pharmacist from modifying or discontinuing medicinal drugs prescribed by health care practitioner; revises responsibilities of consultant pharmacist; requires maintenance of collaborative practice agreements; requires collaborative practice agreements be available upon request by DOH; prohibits consultant pharmacist from diagnosing disease or condition.

HB Referred to:

Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health & Human Services Committee

SB Referred To:

Health Policy

Appropriations Subcommittee on Health and Human Services

Appropriations

 

HB961 (Support)

SB1338 (Support)

SB1444 (Support)

Prescription Drug Benefits

Sponsors: Jackie Toledo (House bill 961) Talking Points

Tom Wright (Senate bill 1338) - Taking Points

Gail Harrell (Senate bill 1444) - Talking Points

Line by line summary of bill HB961 as filed.

HB961 - Provides pharmacy benefit managers have fiduciary duty to specified individuals & entities; provides requirements for services performance, contracts, specified funds, & maximum allowable cost lists; requires pharmacy benefit managers to allow payors access to specified records; requires income & financial benefits to be passed through to payors; requires DFS to investigate violations; requires group health plans, health insurers, & pharmacy benefit managers to base plan beneficiaries' & insureds' coinsurance obligations for prescription drugs on specified drug prices.

SB1338 - Authorizing the Office of Insurance Regulation to examine pharmacy benefit managers; requiring health insurers and health maintenance organizations, or pharmacy benefit managers on behalf of health insurers and health maintenance organizations, to annually report specified information to the office; specifying requirements relating to brand-name and generic drugs in contracts between pharmacy benefit managers and pharmacies or pharmacy services administration organizations, etc.

HB Referred to: TBD

SB Referred to: TBD

 
 HB825

Administration of Vaccines

Sponsor HB825 - Rep Fernandez-Barquin - Talking Points

Revises recommended immunizations or vaccines a pharmacist, or registered intern under certain conditions, may administer

Referred to: Health Quality Subcommittee

Health Care Appropriations Subcommittee

Health and Human Services Committee

 

 HB7045

(Does not resolve issues with PBMs)

Prescription Drug Price Transparency

Sponsor HB7045 - Health Market Reform Subcommittee and Rep Andrade

Requires prescription drug manufacturers to provide notice of drug price increases to health insurers & to provide annual report on drug price increases to DBPR & OIR; provides timelines & documentation requirements for pharmacy audits conducted by certain health insurers, HMOs, or their agents; requires reporting requirements in contracts between pharmacy benefit managers & health insurers & HMOs; requires health insurers & HMOs to submit annual reports to office; requires office to publish such reports & analyses of specified information.

Referred to House Appropriations Committee
 

HB707 (Oppose)

SB1124 (Oppose)

 Legislative Review of Occupational Regulations

 Sponsor: Representative Renner
                  Senator Diaz

Citing this act as the “Occupational Regulation Sunset Act”; establishing a schedule for the systematic review of occupational regulatory programs; providing for the abolition of units or subunits of government and personnel positions responsible for repealed programs; providing for the reversion of certain unexpended funds and the refund of certain unencumbered revenue of a repealed program; requiring the Department of Legal Affairs to prosecute or defend certain pending causes of actions, etc.


 

 

View ALL BILLS filed in the House and Senate